Health Catalyst (HCAT) Competitors

VTEX (NYSE:VTEX) and Health Catalyst (NASDAQ:HCAT) are both small-cap computer software companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations.

Which has higher valuation and earnings, VTEX or HCAT?

VTEX has higher earnings, but lower revenue than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than VTEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VTEX	$226.71M	3.29	$12M	$0.08	50.94
Health Catalyst	$306.58M	0.69	-$69.50M	-$1.51	-1.99

Is VTEX or HCAT more profitable?

VTEX has a net margin of 5.80% compared to Health Catalyst's net margin of -31.67%. VTEX's return on equity of 5.27% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VTEX	5.80%	5.27%	3.66%
Health Catalyst	-31.67%	-7.21%	-3.28%

Does the media refer more to VTEX or HCAT?

In the previous week, VTEX had 1 more articles in the media than Health Catalyst. MarketBeat recorded 7 mentions for VTEX and 6 mentions for Health Catalyst. VTEX's average media sentiment score of 0.44 beat Health Catalyst's score of 0.06 indicating that VTEX is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
VTEX	0 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Health Catalyst	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts recommend VTEX or HCAT?

VTEX currently has a consensus price target of $8.33, suggesting a potential upside of 104.29%. Health Catalyst has a consensus price target of $6.18, suggesting a potential upside of 106.06%. Given Health Catalyst's higher possible upside, analysts plainly believe Health Catalyst is more favorable than VTEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VTEX	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
Health Catalyst	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.42

Do insiders & institutionals hold more shares of VTEX or HCAT?

63.7% of VTEX shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 40.9% of VTEX shares are held by company insiders. Comparatively, 2.6% of Health Catalyst shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Which has more volatility and risk, VTEX or HCAT?

VTEX has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500.

Summary

VTEX beats Health Catalyst on 11 of the 16 factors compared between the two stocks.